Alternative sugars as potential carriers for dry powder inhalations

International Journal of Pharmaceutics

Volumn 270, Issue 1-2, 2004, Pages 297-306

  Steckel, Hartwig ^a   Bolzen, Nina ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Carrier; Dry powder inhaler; Glucose; Mannitol; Particle size distribution

Indexed keywords

BUDESONIDE; DRUG CARRIER; GLUCOSE; MALTITOL; MANNITOL; SORBITOL; XYLITOL;

AEROSOL; ARTICLE; DISPERSION; DRUG FORMULATION; DRY POWDER; HUMIDITY; INHALATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; POWDER INHALER; PRIORITY JOURNAL; WETTABILITY;

EID: 0347021194     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.10.039     Document Type: Article

References (16)

1. Daviskas E., Anderson S.D., Eberl S., Chan H.K., Bautovich G. Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis. Am. J. Crit. Care Med. 159:1999;1843-1848.
2. European Commission - Health & Consumer Protection Directorate, 2002. Provisional statement on the safety of calf-derived rennet for the manufacture of pharmaceutical grade lactose.
3. Food and Drug Administration, 1998. Draft Guidance for Industry on Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products.
4. French D.L., Edwards D.A., Niven R.W. The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation. J. Aerosol Sci. 27:1996;769-783.
5. Ganderton D. Targeted delivery of inhaled drugs: current challenges and future trends. J. Aerosol Med. 12:1999;3-8.
6. Lahrib H., Zeng X.M., Martin G.P., Marriott C., Pritchard J. The use of different grades of lactose as a carrier for aerosolised salbutamol sulphate. Int. J. Pharm. 191:1999;1-14.
7. Lucas P., Anderson K., Potter U.J., Staniforth J.N. Enhancement of small particle size dry powder aerosol formation using an ultra low density additive. Pharm. Res. 16:1999;1643-1647.
8. Moraly, F., Labergerie, E., Lis, J., Lefevre, P., Bouvier, F., 2001. Pulverulent sorbitol and its process of preparation. U.S. Patent 6,365,789.
9. Patton J.S., Platz R.M. Pulmonary delivery of peptides and proteins for systemic action. Adv. Drug Deliv. Rev. 8:1992;179-228.
10. Staniforth J.N. Preformulation aspects of dry powder aerosols. Respir. Drug Deliv. V:1996;65-73.
11. Steckel, H., Bolzen, N., 2003. The effect of drug concentration and addition of a ternary agent on the fine particle fraction of powder mixtures for inhalation. Int. J. Pharm., submitted for publication.
12. Steckel H. Inhalation powders - a simple dosage form for pulmonary delivery? Swiss Pharm. 9a:2002;15-28.
13. Steckel H. Inhalationspulver - Neuere Entwicklungen bei Pulverinhalatoren. PZ Prisma. 3:2003;145-157.
14. Timsina M.P., Martin G.P., Marriott C., Ganderton D., Yianneskis M. Drug delivery to the respiratory tract using dry powder inhalers. Int. J. Pharm. 101:1994;1-13.
15. Wall D.A. Pulmonary absorption of peptides and proteins. Drug Deliv. 2:1995;1-20.
16. Zeng X.M., Martin G.P., Marriott C., Pritchard J. The use of lactose recrystallised from carbopol gels as a carrier for aerosolized salbutamol sulphate. Eur. J. Pharm. Biopharm. 51:2001;55-62.